- Date Published
- April 2017
The Proper Use of the NCPDP™ Telecommunication Standard Version D.0 as it applies to the Implementation of Medicaid Reimbursement Methodologies Based on Actual Acquisition Cost (AAC) Plus a Professional Dispensing Fee
This white paper provides Medicaid agencies and fiscal agents guidance in implementing new acquisition cost based reimbursement rules for covered outpatient drugs. The paper presents common issues experienced to-date in implementing cost based reimbursement with professional dispensing fees. It highlights how to best utilize the NCPDP Telecommunication Standard Version D.0 and leverages best practices for various scenarios such as preferred brands for multisource generic situations and the proper use of the Dispense As Written (DAW)/Product Selection Code (408-D8) field values to inform pharmacies of formulary requirements.
- Date Published
- December 2016
NCPDP’s Recommendations for an Integrated, Interoperable Solution to Ensure Patient Safe Use of Controlled Substances
This latest update (2016) to NCPDP’s PDMP white paper includes an Executive Summary overview, and incorporates updates that address the Comprehensive Addiction and Recovery Act (CARA) enhancements for PDMPs and recent feedback from our EDvocacy efforts. NCPDP’s model solution leverages best practices and existing industry standards to enhance state PDMPs, support interoperability, provide real-time reporting and risk alerts, and access to data, giving providers information in a timely manner, across state lines and across pharmacies.
NCPDP Recommendations for Dose Accumulation Monitoring in the Inpatient Setting: Acetaminophen Case Model
This paper provides the healthcare industry, in particular the pharmacy and inpatient facility sectors, with historical and background information on the patient risks associated with hidden sources of acetaminophen and recommendations for best practices to mitigate those risks through facility management and electronic medical record systems.
This white paper appears in the August 1, 2016 issue of the American Journal of Health-System Pharmacy (AJHP). Click here to access the white paper on AJHP’s website.